Transient hematologic and clinical effect of E21R in a child with end-stage juvenile myelomonocytic leukemia
Data up to Jan 2025
Total Citations Per Year
Abstract
References (7)
Juvenile Myelomonocytic Leukemia
1997 • 215 citations
Juvenile Myelomonocytic Leukemia
1997 • 203 citations
Residue 21 of human granulocyte-macrophage colony-stimulating factor is critical for biological activity and for high but not low affinity binding.
1992 • 112 citations
Specific human granulocyte-macrophage colony-stimulating factor antagonists.
1994 • 105 citations
Inhibition of Granulocyte-Macrophage Colony-Stimulating Factor Prevents Dissemination and Induces Remission of Juvenile Myelomonocytic Leukemia in Engrafted Immunodeficient Mice
1997 • 56 citations
Inhibition of proliferation and induction of apoptosis in juvenile myelomonocytic leukemic cells by the granulocyte-macrophage colony- stimulating factor analogue E21R
1996 • 51 citations
Treatment of juvenile chronic myelomonocytic leukemia by allogeneic bone marrow transplantation.
1994 • 26 citations